RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(24): 1306
DOI: 10.1055/s-2008-1077259
DOI: 10.1055/s-2008-1077259
Pro & Contra | Commentary
Hypertensiologie
© Georg Thieme Verlag KG Stuttgart · New York
Impfung gegen Angiotensin II - pro
Immunization against angiotensin II - proWeitere Informationen
Publikationsverlauf
Publikationsdatum:
04. Juni 2008 (online)
Schlüsselwörter
Hypertonie - Angiotensin II - Impfung
Key words
hypertension - angiotensin II - vaccination
Literatur
- 1 Ambühl P M. et al . A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens. 2007; 25 63-72
- 2 Brown M J. et al . Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci. 2004; 107 167-173
- 3 MullerJE, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989; 79 733-743
- 4 Tissot A C. et al . Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet. 2008; 371 821-827
Prof. Dr. Jürg Nussberger
CHUV-NES 6027, Department of Internal Medicine, Division of Angiology and Hypertension
CH-1011 Lausanne
Telefon: ++ 4121/3140-750
Fax: ++ 4121/3140-761
eMail: Juerg.Nussberger@chuv.ch